Jinhe’s Specialization firstly embodies in its technology in the extraction, separation, purification and synthesis of botanical Anti-cancer drugs such as Paclitaxel, Docetaxel, Irinotecan HCl Trihydrate 99.5%, Etoposide USP31 and their intermediates. After many years of painstaking work, Jinhe has already emerged in the pioneering position in domestic field.

Jinhe’s Specialization secondly manifested in the industrialization of botanical Anti-cancer drugs. Jinhe is able to manage all processes from plant materials to raw material of Anti-cancer drugs.

Jinhe’s Specialization is also manifested in its legalization. All the Yew materials used by JINHE are from imported Taxus leaves, possessing full legitimacy documents.

Jinhe determine to specialize in the industry of Anti-cancer drugs. On one hand, deepen our research of the anticancer substances especially for botanical Anti-cancer drugs, On the other hand, depend on our own professional advantages to extend business to upstream and downstream industries.

Jinhe is determined to be specialized in the industry of Anti-cancer drugs. On one hand, we will deepen our research on the anticancer substances especially on botanical Anti-cancer drugs. On the other hand, we will extend business to upstream and downstream by fully utilizing own expertise in the industry.